-
Venezuelan rescue brings hope to nation in mourning
-
Eala writes history for Philippines in 'electric' Wimbledon atmosphere
-
Macabre night in La Guaira, Venezuela's earthquake epicenter
-
Wolff urges 'perspective' as Russell chases Mercedes' teammate Antonelli
-
Tesla global auto sales jump 25% in 2nd quarter, beating expectations
-
Superb Swiatek, Zverev cruise into Wimbledon last 32
-
Zverev routs Royer to reach Wimbledon third round
-
Ukraine, Russia vow escalation after Moscow attack kills 21 in Kyiv
-
Hot spell roasts eastern US ahead of holiday weekend
-
Slowing US job growth poses midterms challenge for Trump
-
Hamilton cools fans Ferrari fervour
-
Klopp poised to replace Nagelsmann as Germany coach: reports
-
Venezuela's diaspora searches for quake victims on social media
-
More than 400 dead in DR Congo's spreading Ebola outbreak
-
Albanian clashes as protest over Trump-linked resort boils over
-
Hot spell roasts eastern US as holiday weekend approaches
-
Desire key to Pogacar dominance, says former Tour king Froome
-
Superb Swiatek storms into Wimbledon last 32, Zverev waits
-
Rescuers dig out Venezuelan man eight days after quakes
-
Russian strikes kill 21 in biggest ever attack on Kyiv, mayor says
-
Anderson closes in on record Man City move
-
Swiatek sees off Pliskova to race into Wimbledon third round
-
England change five for South Africa Test
-
Dollar down, stocks shine after disappointing US jobs data
-
Lock Alemanno to make 100th Pumas appearance against Scotland
-
US job growth slows, posing questions for Trump before midterms
-
US posts weaker-than-expected job growth in June
-
Chanel eyes menswear with Charvet shirtmaker takeover
-
UK PM says 'deeply sorry' for decades of forced adoptions
-
Chanel eyes menswear with Charvet shirtmaker takevoer
-
Almost 1.2 mn apply for Spain's migrant regularisation
-
'I grabbed my child': Kyiv residents face devastation of biggest Russian barrage of war
-
Ukrainian state ordered Nord Stream sabotage: German prosecutors
-
Former top jockey Dettori breaks ribs in car crash
-
Swiatek, Zverev aiming to lay down Wimbledon markers
-
Rees-Zammit returns to wing as Wales face Fiji
-
German ruling coalition agrees on major reform package
-
Renovations on historic Paris Opera house extended by three years
-
European stocks climb after Asia rout
-
Thailand denies viral claim Macron knelt before king
-
Former Arsenal, Spain midfielder Cazorla retires
-
Spain, Portugal eye World Cup last 16
-
German drone maker raises $1.2 bn as investors pile into defence
-
Russian strikes kill 17 in biggest ever attack on Kyiv, mayor says
-
French scramble to find air conditioners before next heatwave
-
Uruguay veteran Cavani quits Boca Juniors
-
Japan deploys bear cameras in moutains as attacks surge
-
West Ham's Fernandes joins Spurs
-
Germany's Infineon opens major chip plant as EU seeks tech autonomy
-
Bones of contention: More research needed on 'd'Artagnan corpse'
TailorMed CEO Srulik Dvorsky to Lead Panel Session on the Impact of Technology on Specialty Pharmacy Affordability Programs at NASP 2025 Conference
Discussion Will Explore How Emerging Innovations Can Lead to Improved Clinical and Financial Outcomes
NEW YORK, NY / ACCESS Newswire / September 3, 2025 / TailorMed, a leading healthcare technology company, announced that co-founder and chief executive officer Srulik Dvorsky will moderate a panel session on patient affordability initiatives during the National Association of Specialty Pharmacy (NASP) 2025 Annual Meeting & Expo at the Gaylord Resort in Denver, Colorado. The conference takes place September 14-17, 2025. Dvorsky's session, "Leveraging Technology to Scale Affordability Programs in Specialty Pharmacy," will take place on September 14 at 10:10 a.m. MT.
During the session, Dvorsky will be joined by leaders from CenterWell, Prime Therapeutics, and Alivia Health. The panelists will examine how technology is improving access to financial assistance for specialty treatments, resulting in better patient outcomes, operational efficiency, and pharmacy performance.
"Despite the many financial assistance programs available, finding and enrolling patients in these resources is often manual and time-consuming, leading to treatment delays and abandonment," said Dvorsky. "This panel session will educate attendees on how pharmacies can streamline and automate affordability workflows, improving adherence, elevating care quality, and increasing revenue."
TailorMed's expansive network brings together leading pharmacies, providers, life science companies, and other stakeholders to broaden access to financial resources. Since its inception, the company has secured more than $5 billion in financial assistance for patients.
TailorMed representatives will be available throughout the conference at booth #426 for discussions and demonstrations of their affordability solutions.
To learn more about TailorMed, please visit https://tailormed.co/.
About TailorMed
TailorMed is a comprehensive, end-to-end platform designed to eliminate barriers along the entire medication journey, from affordability to access and adherence. TailorMed's innovations in healthcare are transforming how stakeholders-patients, providers, pharmacies, life sciences, and payers-work together to ensure that every patient, across all medical conditions, can receive the treatment they need without delay. TailorMed's enterprise solution manages the full lifecycle of patient support programs, reducing the cost of care and driving better outcomes. Thanks to its partnerships with life sciences, TailorMed creates unparalleled automation through direct integration with manufacturer assistance programs. With the nation's largest Affordability Network, deployed across more than 800 hospitals, 1,300 clinics, and 1,400 pharmacies, TailorMed powers organizations to create a seamless patient experience. Learn more at tailormed.co.
![]()
Contact:
Jennifer Martin
[email protected]
PR Contact:
Glenn Goldberg
Parallel Communications Group
+1 516 776-3282
LinkedIn
𝕏: @Parallel_PR
[email protected]
SOURCE: TailorMed
View the original press release on ACCESS Newswire
M.Robinson--AT